Analysis of Liquidity Ratios
Quarterly Data
Liquidity ratios measure the company ability to meet its short-term obligations.
Liquidity Ratios (Summary)
Cigna Group, liquidity ratios (quarterly data)
Based on: 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).
- Current Ratio
- The current ratio exhibits moderate fluctuations over the observed periods, generally remaining below 1, which suggests the company may consistently hold fewer current assets than current liabilities. Beginning at 0.76 in the first quarter of 2020, the ratio reached a low of 0.70 in the third quarter of 2021 but showed an increasing trend afterward, peaking at 0.86 in the third quarter of 2024 before slightly declining to 0.84 at the end of 2024. This upward movement towards the end of the period could indicate an improvement in short-term liquidity.
- Quick Ratio
- The quick ratio reflects a similar pattern of fluctuation but remains lower than the current ratio throughout, highlighting relatively fewer liquid assets after excluding inventories. Starting at 0.42 in early 2020, the ratio rose sharply to 0.66 by the end of 2020, signaling an enhancement in liquidity excluding inventory. It then declined to a trough of 0.48 in the last quarter of 2021 before stabilizing and gradually increasing again, reaching around 0.61 by late 2023 and maintaining near this level into 2024. The fluctuations suggest variability in liquid asset management or changes in short-term obligations.
- Cash Ratio
- The cash ratio remains the lowest among the liquidity metrics and shows notable volatility throughout the timeframe. It began at 0.13 in early 2020 and saw an increase to 0.32 by the end of 2020, indicating a significant buildup of cash or cash equivalents during this period. Subsequently, the ratio fell and fluctuated between approximately 0.11 and 0.22 with no clear long-term trend. Towards the later periods in 2023 and 2024, the cash ratio appears to slightly decline, ending near 0.14. This suggests a relatively conservative cash position with some variability in immediate cash availability.
- Overall Insights
- The analysis of liquidity ratios over the observed period denotes a company maintaining consistently low liquidity levels with a current ratio below 1, which may imply reliance on liabilities to finance current assets. However, incremental improvements in the current ratio toward the end suggest enhanced liquidity management. The quick ratio’s fluctuations highlight changes in liquid asset holdings excluding inventory, while the cash ratio’s volatility points to varying cash management strategies. Collectively, these indicators demonstrate a cautious liquidity profile with some positive momentum in the more recent quarters.
Current Ratio
Cigna Group, current ratio calculation (quarterly data)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||||||||||||||||||||||
| Current assets | 48,870) | 49,222) | 46,215) | 43,357) | 37,351) | 34,518) | 34,711) | 32,027) | 30,120) | 30,170) | 37,422) | 35,393) | 36,134) | 25,487) | 25,011) | 25,554) | 27,799) | 34,557) | 34,880) | 30,877) | ||||||
| Current liabilities | 57,979) | 57,060) | 55,373) | 51,977) | 48,716) | 47,059) | 47,345) | 44,727) | 41,229) | 41,115) | 45,218) | 43,662) | 43,572) | 36,340) | 34,711) | 33,470) | 36,022) | 43,886) | 42,179) | 40,380) | ||||||
| Liquidity Ratio | ||||||||||||||||||||||||||
| Current ratio1 | 0.84 | 0.86 | 0.83 | 0.83 | 0.77 | 0.73 | 0.73 | 0.72 | 0.73 | 0.73 | 0.83 | 0.81 | 0.83 | 0.70 | 0.72 | 0.76 | 0.77 | 0.79 | 0.83 | 0.76 | ||||||
| Benchmarks | ||||||||||||||||||||||||||
| Current Ratio, Competitors2 | ||||||||||||||||||||||||||
| Abbott Laboratories | 1.67 | 1.60 | 1.68 | 1.60 | 1.64 | 1.74 | 1.64 | 1.68 | 1.63 | 1.86 | 2.01 | 1.85 | 1.85 | 1.83 | 1.79 | 1.75 | 1.72 | 1.70 | 1.57 | 1.43 | ||||||
| Elevance Health Inc. | 1.45 | 1.50 | 1.49 | 1.37 | 1.44 | 1.41 | 1.44 | 1.43 | 1.40 | 1.35 | 1.36 | 1.36 | 1.47 | 1.48 | 1.49 | 1.57 | 1.55 | 1.59 | 1.64 | 1.53 | ||||||
| Intuitive Surgical Inc. | 4.07 | 4.30 | 5.15 | 5.55 | 4.76 | 5.31 | 5.22 | 5.26 | 4.40 | 5.10 | 5.36 | 5.22 | 5.08 | 5.58 | 5.99 | 6.71 | 6.86 | 7.04 | 6.38 | 4.96 | ||||||
| Medtronic PLC | 2.03 | 2.30 | 2.29 | 2.42 | 2.39 | 1.76 | 1.76 | 1.58 | 1.86 | 2.61 | 2.91 | 2.89 | 2.65 | 2.10 | 2.16 | 1.87 | 2.13 | 2.75 | 2.77 | 2.67 | ||||||
| UnitedHealth Group Inc. | 0.83 | 0.91 | 0.88 | 0.85 | 0.79 | 0.80 | 0.80 | 0.81 | 0.77 | 0.82 | 0.77 | 0.78 | 0.79 | 0.77 | 0.77 | 0.74 | 0.74 | 0.82 | 0.84 | 0.75 | ||||||
Based on: 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).
1 Q4 2024 Calculation
Current ratio = Current assets ÷ Current liabilities
= 48,870 ÷ 57,979 = 0.84
2 Click competitor name to see calculations.
- Current Assets
- The current assets exhibit fluctuations over the analyzed periods. From March 31, 2020, to December 31, 2020, there is a noticeable decline from 30,877 million USD to 27,799 million USD. Subsequently, a recovery phase occurs, with current assets increasing to 36,134 million USD by December 31, 2021. The next periods show some volatility, with values decreasing to around 30,120 million USD at the end of 2022, followed by a consistent upward trend through 2023 and into the first three quarters of 2024. The peak is observed in September 2024 at 49,222 million USD, slightly declining thereafter to 48,870 million USD by the end of 2024.
- Current Liabilities
- The current liabilities generally trend upward throughout the period. Starting from 40,380 million USD in March 2020, there is an increase to 43,572 million USD by December 2021, with mild variability during the intervals. After December 2021, current liabilities continue rising steadily, reaching nearly 58,000 million USD by the end of 2024. The increase is relatively consistent, showing a notable expanding financial obligation or accounts payable that the company has within the short term.
- Current Ratio
- The current ratio remains below 1.0 for all periods, indicating that current liabilities consistently exceed current assets. The ratio oscillates between lows around 0.70 and highs near 0.86. Initially, it stays in a range of 0.70 to 0.83 from 2020 through 2021, reflecting tighter liquidity conditions. During 2022, the ratio dips slightly to around 0.73, then exhibits moderate improvement from 0.72 in early 2023 to a peak of 0.86 in September 2024, suggesting improved short-term liquidity. Despite improvement, the ratio remains under 1, highlighting a continuing risk concerning the company's ability to cover short-term obligations solely with current assets.
- Overall Financial Position Insights
- Over the analyzed timeframe, the current liabilities grow more steadily and aggressively than current assets, resulting in a current ratio that consistently stays below 1. This may signify reliance on short-term financing or payables exceeding available liquid resources. However, the upward trend in current assets, especially notable in 2023 and 2024, combined with gradual improvement in the current ratio, indicates some enhancement in working capital management or asset liquidity. The fluctuations in current assets and the sharp rise in liabilities warrant attention to ensure the company maintains sufficient liquidity buffers to meet its short-term liabilities without distress.
Quick Ratio
Cigna Group, quick ratio calculation (quarterly data)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||||||||||||||||||||||
| Cash and cash equivalents | 7,550) | 5,888) | 6,788) | 8,439) | 7,822) | 8,497) | 9,585) | 7,935) | 5,924) | 7,079) | 4,421) | 4,424) | 5,081) | 3,483) | 3,821) | 6,505) | 10,182) | 5,344) | 7,185) | 4,452) | ||||||
| Investments | 665) | 864) | 1,068) | 1,108) | 925) | 1,046) | 872) | 914) | 905) | 783) | 754) | 731) | 920) | 1,374) | 1,305) | 1,477) | 1,331) | 1,324) | 1,190) | 973) | ||||||
| Accounts receivable, net | 24,227) | 27,846) | 25,111) | 20,563) | 17,722) | 19,083) | 18,333) | 17,704) | 17,218) | 17,275) | 18,290) | 16,003) | 15,071) | 16,250) | 15,462) | 13,588) | 12,191) | 13,488) | 12,694) | 11,735) | ||||||
| Total quick assets | 32,442) | 34,598) | 32,967) | 30,110) | 26,469) | 28,626) | 28,790) | 26,553) | 24,047) | 25,137) | 23,465) | 21,158) | 21,072) | 21,107) | 20,588) | 21,570) | 23,704) | 20,156) | 21,069) | 17,160) | ||||||
| Current liabilities | 57,979) | 57,060) | 55,373) | 51,977) | 48,716) | 47,059) | 47,345) | 44,727) | 41,229) | 41,115) | 45,218) | 43,662) | 43,572) | 36,340) | 34,711) | 33,470) | 36,022) | 43,886) | 42,179) | 40,380) | ||||||
| Liquidity Ratio | ||||||||||||||||||||||||||
| Quick ratio1 | 0.56 | 0.61 | 0.60 | 0.58 | 0.54 | 0.61 | 0.61 | 0.59 | 0.58 | 0.61 | 0.52 | 0.48 | 0.48 | 0.58 | 0.59 | 0.64 | 0.66 | 0.46 | 0.50 | 0.42 | ||||||
| Benchmarks | ||||||||||||||||||||||||||
| Quick Ratio, Competitors2 | ||||||||||||||||||||||||||
| Abbott Laboratories | 1.05 | 1.00 | 1.02 | 0.95 | 1.00 | 1.04 | 1.00 | 1.07 | 1.06 | 1.22 | 1.33 | 1.21 | 1.28 | 1.25 | 1.19 | 1.16 | 1.14 | 1.01 | 0.93 | 0.83 | ||||||
| Elevance Health Inc. | 1.32 | 1.34 | 1.32 | 1.23 | 1.30 | 1.29 | 1.32 | 1.31 | 1.27 | 1.21 | 1.22 | 1.23 | 1.33 | 1.33 | 1.35 | 1.43 | 1.42 | 1.45 | 1.49 | 1.37 | ||||||
| Intuitive Surgical Inc. | 3.00 | 3.21 | 3.94 | 4.31 | 3.83 | 4.44 | 4.36 | 4.30 | 3.56 | 4.19 | 4.49 | 4.40 | 4.34 | 4.66 | 5.12 | 5.76 | 5.96 | 5.93 | 5.40 | 4.00 | ||||||
| Medtronic PLC | 1.31 | 1.46 | 1.42 | 1.51 | 1.54 | 1.18 | 1.18 | 1.01 | 1.30 | 1.87 | 2.07 | 2.06 | 1.91 | 1.58 | 1.63 | 1.37 | 1.50 | 2.05 | 2.02 | 1.95 | ||||||
| UnitedHealth Group Inc. | 0.75 | 0.83 | 0.81 | 0.79 | 0.73 | 0.75 | 0.74 | 0.75 | 0.70 | 0.77 | 0.71 | 0.72 | 0.72 | 0.71 | 0.71 | 0.68 | 0.68 | 0.75 | 0.76 | 0.66 | ||||||
Based on: 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).
1 Q4 2024 Calculation
Quick ratio = Total quick assets ÷ Current liabilities
= 32,442 ÷ 57,979 = 0.56
2 Click competitor name to see calculations.
The financial data reflects the quarterly trends in liquidity for the analyzed periods, focusing on total quick assets, current liabilities, and the resulting quick ratio.
- Total Quick Assets
- The total quick assets show variability across the observed periods. There was a notable increase from March 2020 (17,160 million USD) to December 2020 (23,704 million USD), indicating improved liquid asset levels in the first year. In 2021, the value fluctuated with a slight decline in midyear but remained around the 20,000 million USD level. The years 2022 and 2023 displayed a general upward trend, peaking at 28,790 million USD in June 2023. However, the last recorded periods in 2024 showed mixed movements with an initial increase to 34,598 million USD in September, followed by a decline to 32,442 million USD in December 2024, suggesting some volatility in quick assets at year-end.
- Current Liabilities
- Current liabilities started at 40,380 million USD in March 2020 and generally trended upward over the period. The earliest phase shows a decline by December 2020 (36,022 million USD). From 2021 onwards, liabilities increased substantially, reaching a high of 57,979 million USD by December 2024. This steady rise suggests growing short-term obligations, with particularly sharp increases during the last two years, possibly indicating greater operational or financing demands.
- Quick Ratio
- The quick ratio, representing the liquidity coverage of current liabilities by liquid assets, began at a low 0.42 in March 2020, improving to a peak of 0.66 in December 2020, signifying enhanced liquidity that year. In 2021, the ratio declined to below 0.5 by year-end, despite the stable quick assets, due to rising current liabilities. The subsequent years saw the quick ratio hovering around 0.58 to 0.61, with minor fluctuations, indicating relatively stable but moderate liquidity. The ratio fell slightly to 0.56 by December 2024, suggesting a modest weakening in the company’s ability to cover current liabilities with quick assets compared to earlier quarters.
Overall, the data reveals increasing quick assets over time, offset by an even greater rise in current liabilities, leading to a quick ratio that, while improved compared to the initial period, remains under 1. This indicates that the company maintains a conservative liquidity margin but faces growing short-term obligations that could pressure liquidity if the trend continues. The fluctuations toward the end of the period warrant monitoring to ensure sufficient liquidity is maintained.
Cash Ratio
Cigna Group, cash ratio calculation (quarterly data)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||||||||||||||||||||||
| Cash and cash equivalents | 7,550) | 5,888) | 6,788) | 8,439) | 7,822) | 8,497) | 9,585) | 7,935) | 5,924) | 7,079) | 4,421) | 4,424) | 5,081) | 3,483) | 3,821) | 6,505) | 10,182) | 5,344) | 7,185) | 4,452) | ||||||
| Investments | 665) | 864) | 1,068) | 1,108) | 925) | 1,046) | 872) | 914) | 905) | 783) | 754) | 731) | 920) | 1,374) | 1,305) | 1,477) | 1,331) | 1,324) | 1,190) | 973) | ||||||
| Total cash assets | 8,215) | 6,752) | 7,856) | 9,547) | 8,747) | 9,543) | 10,457) | 8,849) | 6,829) | 7,862) | 5,175) | 5,155) | 6,001) | 4,857) | 5,126) | 7,982) | 11,513) | 6,668) | 8,375) | 5,425) | ||||||
| Current liabilities | 57,979) | 57,060) | 55,373) | 51,977) | 48,716) | 47,059) | 47,345) | 44,727) | 41,229) | 41,115) | 45,218) | 43,662) | 43,572) | 36,340) | 34,711) | 33,470) | 36,022) | 43,886) | 42,179) | 40,380) | ||||||
| Liquidity Ratio | ||||||||||||||||||||||||||
| Cash ratio1 | 0.14 | 0.12 | 0.14 | 0.18 | 0.18 | 0.20 | 0.22 | 0.20 | 0.17 | 0.19 | 0.11 | 0.12 | 0.14 | 0.13 | 0.15 | 0.24 | 0.32 | 0.15 | 0.20 | 0.13 | ||||||
| Benchmarks | ||||||||||||||||||||||||||
| Cash Ratio, Competitors2 | ||||||||||||||||||||||||||
| Abbott Laboratories | 0.56 | 0.52 | 0.52 | 0.47 | 0.53 | 0.54 | 0.57 | 0.66 | 0.66 | 0.74 | 0.75 | 0.65 | 0.78 | 0.75 | 0.71 | 0.67 | 0.60 | 0.46 | 0.46 | 0.34 | ||||||
| Elevance Health Inc. | 0.85 | 0.90 | 0.86 | 0.82 | 0.87 | 0.90 | 0.92 | 0.91 | 0.86 | 0.87 | 0.86 | 0.86 | 0.95 | 0.97 | 0.97 | 1.08 | 1.04 | 1.04 | 1.10 | 0.95 | ||||||
| Intuitive Surgical Inc. | 2.30 | 2.52 | 3.20 | 3.49 | 3.15 | 3.86 | 3.77 | 3.59 | 2.90 | 3.50 | 3.78 | 3.58 | 3.66 | 3.98 | 4.42 | 5.04 | 5.30 | 5.27 | 4.85 | 3.44 | ||||||
| Medtronic PLC | 0.74 | 0.85 | 0.80 | 0.87 | 0.88 | 0.77 | 0.79 | 0.63 | 0.85 | 1.26 | 1.37 | 1.36 | 1.27 | 1.17 | 1.18 | 0.99 | 1.06 | 1.33 | 1.27 | 1.25 | ||||||
| UnitedHealth Group Inc. | 0.28 | 0.37 | 0.33 | 0.35 | 0.34 | 0.42 | 0.44 | 0.43 | 0.36 | 0.46 | 0.36 | 0.37 | 0.36 | 0.35 | 0.35 | 0.33 | 0.33 | 0.37 | 0.42 | 0.35 | ||||||
Based on: 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).
1 Q4 2024 Calculation
Cash ratio = Total cash assets ÷ Current liabilities
= 8,215 ÷ 57,979 = 0.14
2 Click competitor name to see calculations.
The quarterly financial data reveals varying trends across three main metrics: total cash assets, current liabilities, and the cash ratio, measured over a five-year period.
- Total Cash Assets
- Total cash assets exhibit considerable fluctuations throughout the observed timeframe. Beginning at 5,425 million USD in the first quarter of 2020, cash assets peaked at 11,513 million USD by the end of the same year. Subsequently, there is a general declining trend during 2021, with values falling to as low as 4,857 million USD in the third quarter, followed by moderate recovery phases through 2022 and 2023. The highest level was observed in the second quarter of 2023 at 10,457 million USD. Toward the end of the period, a mixed pattern persists, with cash assets declining again and ending at approximately 8,215 million USD in the last reported quarter of 2024. The fluctuations suggest variable liquidity management and possibly seasonal or operational influences on cash holdings.
- Current Liabilities
- Current liabilities show a steady upward trajectory over the analyzed quarters. Starting at 40,380 million USD in the first quarter of 2020, liabilities increased moderately with intermittent periods of acceleration. By the end of 2021, liabilities expanded notably, reaching approximately 43,572 million USD. This upward trend continues unabated through 2022 and 2023, with significant increments each quarter. The liabilities further escalate into 2024, peaking at nearly 57,979 million USD, indicating a consistent growth in short-term financial obligations. This sustained increase in liabilities could reflect expanding operational scale, increased short-term borrowing, or growing payables.
- Cash Ratio
- The cash ratio, which is a liquidity metric comparing cash assets to current liabilities, remains generally low throughout the entire period. Initially recorded at 0.13 in early 2020, it rises to a peak of 0.32 at the end of 2020, coinciding with the high level of cash assets recorded during that quarter. Following this peak, the ratio declines and fluctuates mostly in the 0.11 to 0.22 range, indicating that despite some periods of improvement, cash coverage of current liabilities remains limited. The downward trend towards the later quarters of 2024, with ratios nearing 0.12 to 0.14, indicates that the growth in current liabilities is not matched proportionally by cash assets, which may signal tightening liquidity conditions or a strategic decision to maintain lower cash buffers relative to short-term liabilities.
In summary, the data outlines a scenario of increasing current liabilities accompanied by volatile cash assets, resulting in generally low and fluctuating cash ratios over the five-year span. This points to potential challenges in short-term liquidity and the need for careful cash management to duly support the growing obligations.